Irene Gañán‐Gómez

Toll-like receptor alterations in myelodysplastic syndrome

Yue Wei, Sophie Dimicoli, Carlos E. Bueso‐Ramos et al. · Leukemia · 2013 · 158 citations · Full text

Toll-like Receptors, Toll-like Receptor Alterations, Autoimmune Disease +6

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

Matteo Marchesini, Yamini Ogoti, Elena Fiorini et al. · Cancer Cell · 2017 · 158 citations · Full text

Hematological Malignancy, Transcriptional Regulation, Immunology +7

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Koji Sasaki et al. · Blood Advances · 2019 · 111 citations · Full text

Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome

Simona Colla, Derrick Sek Tong Ong, Yamini Ogoti et al. · Cancer Cell · 2015 · 103 citations · Full text

Myelodysplastic Syndrome, Bone Marrow Failure, Genetics +6

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

Yue Wei, R Chen, Sophie Dimicoli et al. · Leukemia · 2013 · 86 citations

Hematological Malignancy, Immunogenetics, Innate Immunity Signaling +6